NCT02698891 2022-05-06
Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
Clinical Trials
8 trialsNCT03946683 2021-02-18
Cyberknife for Early Stage Breast Cancer
NYU Langone Health
Phase NA Completed
NCT03102307 2021-02-03
Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)
Kliniken Essen-Mitte
Completed
NCT02485678 2020-09-03
AToM
Ontario Clinical Oncology Group (OCOG)
Phase NA Completed
NCT01162200 2020-08-20
Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT02816112 2020-05-27
REaCT-TC2
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02816164 2019-09-06
REaCT-G2
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02428114 2017-09-29
React-G
Ottawa Hospital Research Institute
Completed